期刊文献+

吡非尼酮致皮肤光敏反应的文献分析 被引量:1

Literature analysis of pirfenidonein induced photosensitivity
原文传递
导出
摘要 目的:研究治疗肺间质纤维化新药吡非尼酮导致皮肤光敏反应这一特殊不良反应的一般规律,为临床安全合理用药提供参考依据。方法:采用文献回顾性研究的方法,对吡非尼酮导致光敏反应患者的临床资料进行统计分析。结果:吡非尼酮导致患者光敏反应是一种光毒性反应,不良反应发生可能与生活方式、用药剂量有关,出现光敏反应建议暂停药物治疗,对症处理。结论:临床应用吡非尼酮应加强预防与用药监测,以避免和减少光敏反应的发生。 OBJECTIVE To investigate the photosensitivity induced by pirfenidone and provide a reference for rational drug use.METHODS Medical records of the photosensitivity induced by pirfenidone were summarized and analyzed.RESULTSThe photosensitivity induced by pirfenidone was a phototoxic reaction,and was related with lifestyle and dose.It was ecommended immediate withdrawal and symptomatic treatment when photosensitivity occurred.CONCLUSION Drug monitoring and prevention should be enhanced for clinical application of pirfenidone,to avoid and reduce the occurrence of photosensitivity.
作者 武丹威 邢颖 甄健存 WU Dan-wei XING Ying ZHEN Jiamcun(Jishuitan Hospital, Beijing 100035, China)
机构地区 北京积水潭医院
出处 《中国医院药学杂志》 CAS 北大核心 2017年第6期538-540,共3页 Chinese Journal of Hospital Pharmacy
关键词 吡非尼酮 光敏反应 不良反应 pirfenidone photosensitivity adverse reaction
  • 相关文献

参考文献4

二级参考文献96

  • 1马臻,王尊元,沈正荣.吡非尼酮的合成[J].中国医药工业杂志,2006,37(6):372-373. 被引量:8
  • 2Raghu G; Collard H R, Egan J J, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management [J]. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
  • 3Rafii R, Juarez M M, Albertson T E, et al. A review of current and novel therapies for idiopathic pulmonary fibrosis [J]. J Thorac Dis, 2013, 5(1): 48-73.
  • 4Adamali H I, Maher T M. Current and novel drug therapies for idiopathic pulmonary fibrosis [J]. Drug Des Devel Ther, 2012(6): 261-271.
  • 5Bando M, Hosono T, Mato N, et al. Long-term efficacy of inhaled N-acetylcysteine in patients with idiopathic pulmonary fibrosis [J]. Int Med, 2010, 49(21): 2289-2296.
  • 6Kisseleva T, Brenner D A. Mechanisms of fihrogenesis [J]. Exp Biol Med (Maywood), 2008, 233(2): 109-122.
  • 7Chan A L, Rafii R, Louie S, et al. Therapeutic update in idiopathic pulmonary fibrosis [J]. Clin Rev Allergy Immunol, 2013, 44(1): 65-74.
  • 8Lin X, Yu M, Wu K, et al. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro [J]. Invest Ophthalmol Vis Sci, 2009, 50(8): 3763-3770.
  • 9Lee B S, Margolin S B, Nowak R A. Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production [J]. J Clin Endocrinol Metab, 1998, 83(1): 219-223.
  • 10Nakayama S, Mukae H, Sakamoto N, et al. Pirfenidone inhibits the expression of HSP47 in TGF-betal-stimulated human lung fibroblasts [J]. Life Sci, 2008, 82(3/4): 210-217.

共引文献189

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部